from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1600/hisC1

LFCtreatmentdescriptionclass of inhibitor

-0.939

Amikacinug/mL Amikacintranslation

-0.505

Cap5-10ug/mL Capreomycintranslation

-1.607

Rox10-50 ug/mL Roxithromycintranslation

-0.350

SM2-5 ug/mL Streptomycintranslation

-0.006

Tet5-10 ug/mL Tetracyclinetranslation

-0.006

Rif0.2-5ug/mL Rifampicintranscription

-0.181

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.277

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.696

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.056

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.021

Clofazimine10-13 ug/mL Clofaziminerespiration

0.003

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.378

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.336

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.726

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.122

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.721

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.196

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.808

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.373

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.253

KCN5-20 ug/mL Potassium cyaniderespiration

0.401

NaN30.2-2 mM Sodium aziderespiration

0.765

Nigericin50 uM Nigericinrespiration

0.248

TRC10-150 ug/mL Triclosanrespiration

0.158

TRZ10-25 ug/mL Thioridazinerespiration

1.522

Valinomycin0.5-10 uM Valinomycinrespiration

1.014

ZnSO42 mM ZnSO4respiration

0.359

menadione6-10 ug/mL Menadionerespiration

-0.542

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.531

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.017

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.013

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.719

NRP_1Non-replicating persistence stage 1dosRassociated

-0.694

Amp0.2mg/mL AmpicillincellWall

-0.391

Cephalexin20-100 ug/mL CephalexincellWall

-0.159

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.692

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.512

EMB10-20 ug/mL EthambutolcellWall

0.171

Eta12-40 ug/mL EthionamidecellWall

-0.131

INH0.2-0.4 ug/mL IsoniazidcellWall

0.185

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.025

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.441

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.238

BZA0.12 mg/mL BenzamidearomaticAmides

-0.068

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.149

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.230

H2O24 mM hydrogen peroxideDNAdamaging

-0.386

Levo10 ug/mL LevofloxacinDNAdamaging

-0.605

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.789

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.265

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.308

UVUV-irradiationDNAdamaging

0.763

ARP41-4 ug/mL Antitubercular compound ARP4?

0.069

Antimycin12.5-50 ug/mL Antimycin A?

-0.106

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.132

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.201

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.068

PA8240.2-2 ug/mL PA-824?

1.884

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.327

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.140

Verapamil50 uM Verapamil?

-0.193

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.317

methoxatin10-20 ug/mL Methoxatin?